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Abstract: In recent decades, the incidence and prevalence of nontuberculous mycobacteria (NTM)
have greatly increased, becoming a major worldwide public health problem. Among numerous
NTM species, the Mycobacterium avium complex (MAC) is the most predominant species, causing
disease in humans. MAC is recognized as a ubiquitous microorganism, with contaminated water
and soil being established sources of infection. However, the reason for the recent increase in
MAC-associated disease has not yet been fully elucidated. Furthermore, human MAC infections
are associated with a variety of infection sources. To improve the determination of infection
sources and epidemiology of MAC, feasible and reliable genotyping methods are required to
allow for the characterization of the epidemiology and biology of MAC. In this review, we discuss
genotyping methods, such as pulsed-field gel electrophoresis, a variable number of tandem repeats,
mycobacterial interspersed repetitive-unit-variable number of tandem repeats, and repetitive element
sequence-based PCR that have been applied to elucidate the association between the MAC genotypes
and epidemiological dominance, clinical phenotypes, evolutionary process, and control measures of
infection. Characterizing the association between infection sources and the epidemiology of MAC will
allow for the development of novel preventive strategies for the effective control of MAC infection.
Keywords: Mycobacterium avium complex (MAC); genotyping; pulsed-field gel electrophoresis (PFGE);
variable number of tandem repeats (VNTR); mycobacterial interspersed repetitive-unit-variable
number of tandem repeats (MIRU-VNTR); repetitive element sequence-based PCR (rep-PCR); clinical
epidemiology; environmental epidemiology
1. Introduction
Mycobacterium avium complex (MAC), a slow-growing mycobacterium that inhabits a wide range
of sources, such as soil, water, domestic and wild animals, and foodstuffs, causes various forms of
disease in humans, other mammals, and birds [1]. MAC can survive and multiply in a wide range
of environmental conditions, including low pH, extreme temperatures, chlorine or ozone treatment,
and low oxygen levels, and thus thrive in various environments due to their ability to utilize various
substances as nutrients [2,3]. Moreover, MAC is known to cause a variety of diseases, including
tuberculosis-like diseases in humans and birds, disseminated infections in immunocompromised
patients, lymphadenitis in humans and mammals, and chronic enteric disease in ruminants [2,4]. In
addition, the M. avium subspecies, paratuberculosis (MAP), a causative agent of Johne’s disease in
ruminants, has been identified in specimens from Crohn’s disease, and has been proposed to be related
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to each other [5]. The prevalence of nontuberculous mycobacteria (NTM) lung disease has recently
increased across the world, wherein MAC has been the predominant mycobacterium in most countries,
responsible for 47% of the cases of NTM infection [6,7]. In addition, a study published in the early
1990s revealed that the incidence of MAC in AIDS patients ranged from 20–40% [8,9]. These findings
indicate that MAC is a representative microorganism among NTM species which cause human disease.
Since public health authorities do not typically monitor NTM disease, relevant epidemiological and
surveillance data are not readily available or are inaccurate, indicating that defining the epidemiology
of NTM is more difficult than Mycobacterium tuberculosis (MTB) [7]. Unlike MTB, there is no definite
data indicating the transmission of bacteria between humans, such that the concept that it is acquired
from the environment takes precedence in NTM [7]. Environmental infectious agents may have
an impact on the specific infection and transmission pathways of MAC, potential infections, and
disease recurrence; however, these have not yet been fully defined. Although various epidemiological
studies on MAC have been conducted using different genotyping techniques, there is still a lack of
literature presenting the epidemiological characteristics, biology, and origins of MAC from humans,
animals, and environmental sources using definitive genotyping techniques. As such, in this review,
we discuss the application of the major genotyping methods for the characterization of MAC, including
restriction fragment length polymorphisms (RFLP), pulsed-field gel electrophoresis (PFGE), variable
number of tandem repeats (VNTR), mycobacterial interspersed repetitive-unit (MIRU)-VNTR, and
repetitive element sequence-based PCR (rep-PCR), and deal with the associations of genotypes with
epidemiological investigation, diagnosis, clinical phenotypes, evolution, transmission mode, and
prevention of MAC in order to control these organisms more effectively.
2. Significance of Molecular Genotyping Methods Applied to MAC
Traditionally, MAC is thought to consist of two species, M. avium and M. intracellulare [10,11].
Recent advances in systematic analysis have allowed for the identification and classification
of new (sub) species within MAC at the molecular level, such as Mycobacterium chimaera [12],
Mycobacterium colombiense [13], Mycobacterium arosiense [14], Mycobacterium vulneris [15], Mycobacterium
bouchedurhonense, Mycobacterium marseillense, Mycobacterium timonense [16], and Mycobacterium
paraintracellulare [17], as well as newly defined M. intracellulare subspecies, including M. intracellulare
subsp. yongonense [18,19] and Mycobacterium indicus pranii [19]. Additionally, M. avium has been
divided into four subspecies: M. avium subsp. avium (MAA) [20], M. avium subsp. hominissuis
(MAH) [21], M. avium subsp. paratuberculosis (MAP), and M. avium subsp. silvaticum (MAS) [20].
With the development of molecular diagnostic methods, novel species have been recently identified
and published within the MAC family, as phenotypic tests do not readily distinguish between
closely-related species and subspecies [22]. An important example of identifiable phenotypic tests
in MAC is the fact that MAP requires mycobactin J for in vitro growth, and MAS is unable to grow
in an egg-based medium, being stimulated to grow by pyruvate instead [23]. Due to the difficulty
involved in performing species identification using these phenotypic methods, attempts have been
made to characterize MAC classification using molecular genotyping methods, such as sequence
analysis of specific targets, detection of species-specific insertion elements, and restriction enzyme
analysis, thus providing new methods for the identification of novel MAC species and strains among
others, providing new opportunities for the identification of novel MAC species and strains [23].
MAC differs in virulence and ecology within the constituent bacteria, among which species such
as MAA, MAP, MAH, and MAS are strict pathogens; however, M. intracellulare is considered to be
an environmental bacterium that is widely distributed in soil and water [24]. Additionally, a new
related species and a new subspecies of M. intracellulare were isolated and identified in patients with
pulmonary disease, lymphadenitis, or disseminated infection; however, isolation from the environment
or animals was not reported. Later, the mechanical meaning of MAC will be described in detail,
but in short, M. avium can be excreted from infected animals and contaminate the environment, so
that it is considered as possible to be transmissive among humans, animals, and the environment.
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However, M. intracellulare has been described as being in the environment, such as soil and water,
and its infection has been attributed to the environment. Thus, there have been discussions that
the two bacteria must not be bound together by MAC because of different infectious sources [1,25].
Among other factors, water is considered to be the main source of MAC infection in humans [26].
Indeed, MAC has also been detected in samples of hospital water distribution systems [27]. It is
believed that drinking water systems contribute to the dissemination of MAC infection [28,29]. A
statistically significant correlation between freshwater exposure of patients and MAC infection has
been reported; however, the studies did not report a microbiological association, and only partial
evidence for direct transmission was observed [30,31]. Thus, while MAC is an important public
health pathogen, since it resides in the environment, animals, and humans, the epidemiology of MAC
organisms remains ambiguous.
To date, the optimal approach by which to determine the epidemiology of MAC and characterize
the risk factors associated with sources of infection is molecular genotyping. Although the sequencing
of 16S rRNA genes is key to the identification of MAC at the species level, the sequencing of other target
genes, including rpoB, hsp65, and the internal transcribed spacer (ITS) has not yet been determined for
the genotypes of all MAC organisms [22]. Therefore, RFLP, PFGE, and VNTR analysis have been used
to distinguish MAC isolates, wherein various PCR-based analysis that can be highly reproducible and
much faster than these methods have been developed and used. New strains are constantly being
classified as MAC species or subspecies, and their infectious sources may be more varied than the
initial expectations. In particular, the data on the MAC genotyping analysis of the MAC obtained
thus far is extensive, but not clear due to the genetic characteristics of the species/subspecies, which
have not yet been clearly defined. Therefore, it is necessary to prepare criteria and a basis for the
selection of the appropriate molecular genotyping methods for each MAC organism by summarizing
the discrimination power and epidemiological results derived from each molecular genotyping method
for MAC isolates. In the following sections, we discuss several genotyping methods, including PFGE,
VNTR, VNTR-MIRU, and rep-PCR, which are representative and widely applied to mycobacterial
species, including MAC, and describe the epidemiological results obtained so far.
3. PFGE for MAC and Their Implications in Epidemiological Studies
PFGE recognizes and cuts specific bacterial genomic DNA sequences using restriction
endonuclease, and effectively separates large DNA fragments by periodically changing the direction
of the electric field [32]. The unique band patterns in PFGE are generated either by mutations that
create or remove enzyme breakpoints, or by genetic changes, like deletions or insertions, which
increase or decrease the band sizes [33]. Although PFGE is labor-intensive and requires a high level of
operator skill, it is considered the “gold standard” of genotyping in epidemiological studies of bacterial
infections, including MAC [34–36]. The usefulness of PFGE analysis in epidemiological studies is
described below.
3.1. Investigation of MAC for Co-Infection and Relapse
Arbeit et al. (1993) reported on a case in which a patient was simultaneously infected with two
different strains. Additionally, the study addressed the need for alternatives for the diagnosis and
treatment of co-infection cases [34]. The analysis of the isolates from patients with AIDS revealed
that 33% of the patients had polyclonal infections. The cases tested positive for both M. avium and M.
intracellulare, which indicated that co-infection is common among patients with AIDS [37]. Additionally,
the analysis of MAC infection profiles based on the symptoms revealed that polyclonal MAC infection
was common in patients with nodular bronchiectasis, whereas monoclonal infection was more common
in patients with fibrocavitary lung disease. Interestingly, M. intracellulare infection was dominant in
both nodular bronchiectasis and fibrocavitary lung disease [38].
Among the co-infection cases, the study of recurring MAC pulmonary disease began with the
analysis of M. avium infection in patients with AIDS [39]. Three strains were sequentially isolated
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from one patient, wherein each strain exhibited varying resistance to clarithromycin, despite all three
strains being found in the same patient. Additionally, 97.4% of the patients who exhibited a positive
culture after 2–15 months of treatment had the same strains as those before treatment [39]. This study
suggests that M. avium relapse in patients with AIDS may be caused by the same strain acquiring
resistance to antibiotics or due to the reappearance of latent strains present in the tissue [39]. Wallace
et al. (2002) conducted a follow-up study of MAC recurrence after macrolide treatment, in which only
4 out of 36 cases of MAC were infected by the same strain [40]. Additionally, 5 of the 7 MAC relapse
cases observed after ending the treatment too early were caused by the same strains, wherein the
newly infected strains were not resistant to macrolide treatment [40]. These findings indicated that the
macrolide treatments in these patients were complete and that the relapse from the same strain was
rare, most likely being caused by different strains [40]. This was similar to the findings of Jhun et al.
(2018) using rep-PCR, demonstrating that the continuous influx of bacteria and infection is the main
issue, rather than the recurrence of the same bacteria [41].
3.2. Relationship among Environment, Animal, and Human Isolates
A study was conducted on the assumption that the residence of the patients studied was a
contributing factor to the relapse of MAC infection, as MAC was found only in the bathroom
within their residences [31]. Additionally, the detection rate of MAC in the patients’ bathrooms was
significantly higher than that in the general public space. Of the 49 patients, two patients had the
same strains as those detected in their bathroom [31]. Several other studies have also examined the
correlation between strains of MAC detected in living quarters and the isolates obtained from the
patients [42,43]. In particular, the strains detected in one patient with hypersensitivity pneumonitis
who was occupationally exposed to water used for cleaning the pool filter matched the strains detected
in the workplace [44]. Additionally, studies on MAC infection caused by aerosols generated by
heater-cooler devices used in research and heart surgery revealed that devices used in medical and
research facilities can be sources of MAC infection, indicating the possibility that these types of MAC
infection will continue in the future, despite the development of hygiene or modern medicine [45].
The study of the infectious environment of M. avium compared the genotypes of strains found
in reservoirs, households, commercial buildings, hospitals, and clinical isolates in Los Angeles and
California. The highest correlation was observed between the isolates obtained from hospitals and
patients, indicating in-hospital infection. This supported the hypothesis that M. avium infection is
possible through drinking water [46]. Subsequently, Kyriakopoulos et al. (2000) reported that infection
in patients was caused by exposure to an environment containing the related strains rather than by
clinical features, as the strains of similar genotypes were isolated in both HIV-negative and -positive
patients. This study addressed the need for further analysis [47].
Drovska et al. (2003) used MAA and MAS isolation panels from 27 different hosts and environments
to identify MAA (RFLP type F-C3) in all birds diagnosed with avian tuberculosis [48]. MAA (RFLP type
F-C3) was also found in the aviary environment [48]. This study showed that the MAA of a specific
RFLP type could be introduced in a flock and subsequently spread rapidly among susceptible birds,
resulting in the establishment of a potentially infectious environmental reservoir [49]. In another study,
MAA was isolated from captive water birds and from environmental samples from aviaries housing
naturally infected captive water birds. The results confirmed that these strains were equally virulent in
pullets [49]. These results suggested that the local environment could spread MAA—the causative
agent of avian tuberculosis—among zoo and farm animals, as well as their caregivers [49]. As discussed
above, several studies have confirmed that MAA excreted from MAA-infected animals (i.e., in feces)
contaminate the environment and that the environment might play a role in MAA transmission.
Meanwhile, interestingly, when by-products of hens were fed to second-stage larvae of the
blowflies Calliphora vicina and Lucilia sericata, MAA was recovered from the C. vicina and L. sericata
larvae four days after infection [50]. Moreover, in the same study, MAP (RFLP type B-C1) were
detected in two samples including the intestinal mucosa of two cows showing clinical signs of Johne’s
Microorganisms 2020, 8, 98 5 of 25
disease, and captured blowfly C. vicina that was in contact with the intestinal mucosa present in
the slaughterhouse waste container [50]. In addition, MAP was also detected in captured blowflies
on the following day, in the absence of cows with Johne’s disease [50]. These results showed that
both the vector (the blowfly) and the larvae of the vector may participate in spreading the agents
of mycobacterial infection, reinforcing the importance of proper hygiene during handling animals
infected with, or affected by, MAA or MAP [50].
Feizabadi et al. (1996) evaluated the association between human and animal isolates using
multilocus enzyme electrophoresis (MEE). A low correlation between bird and human isolates, and a
high correlation between pig and human isolates were reported [51]. The results of MEE and PFGE
showed that certain strains of M. avium could be transmitted between birds and pigs. However, there
was no definite evidence of transmission to humans [51]. Johansen et al. (2007) reported that MAH pig
isolates showed regional differences, but no differences in terms of clinical type or region in genotyping
analysis on MAH human and MAH pig isolates [52]. There was a significant difference in genotype
between the MAH human and MAH pig isolates, although one human isolate was identical to the pig
isolate [52]. IS1311 analysis and PFGE analysis using 520 MAPs isolated from several animals showed
that the bovine isolates had a similar genotype, while those from sheep and goats were different [53].
Based on the above results, genotypes could be classified according to host specificity within the
same species.
However, Tirkkonen et al. (2010) demonstrated significant similarities between MAH human
and MAH pig isolates [54]. Hence, further investigations need to be done to determine whether one
species (human or pig) can alternately become a source of infection for another species, and whether
the infection has been transmitted through common environmental sources. These results might offer
insight into the epidemiology of MAH among humans and pigs. Major sources of porcine MAH
infection are believed to be peat and sawdust, which are frequently used as bedding in the swine
industry [55–58]. However, recent results indicated that the role of feces and peat in swine infections
cannot be defined accurately. Nonetheless, the detection of MAH in feces of naturally infected and
experimental pigs offers support for MAH infection by the fecal–oral route [59,60]. Moreover, human
MAH infection was traced to drinking water systems, saunas, pools, and organic environmental
substances [28,46,60,61], which can cause severe disseminated infections in immunocompromised
patients, such as those infected with HIV [3,10].
3.3. Comparison of PFGE with Other Genotyping Methods
PFGE, IS1245-PCR, and IS1311-PCR analyses revealed that M. avium isolates from a hospital
exhibited varied genotypes. The IS element-PCR analysis detected 2–3 patterns, whereas PFGE analysis
detected 5–6 groups, indicating the limitations of IS element analysis [62]. M. intracellulare isolated 21
from patients suffering from bronchiectasis were analyzed by VNTR and PFGE analysis. The patterns
22 of the two analyses were similar, suggesting that VNTR may be a suitable alternative to PFGE
for use in distinguishing recurrence [63]. In addition, M. intracellulare was subjected to antibiotic
susceptibility testing, sequencing of the hsp65 and rpoB genes, PFGE, Multilocus sequence typing
(MLST), MIRU-VNTR, and VNTR [64]. The discrimination power for M. intracellulare was found to be
higher in order of PFGE, VNTR, MLST. Furthermore, it was reported to be useful for distinguishing
recurrence [64].
In more recent studies, PFGE and whole-gene sequencing (WGS) have been used in combination.
After the sequential isolation of bacteria from chronic patients, one strain was continuously infected
with PFGE. Interestingly, WGS analyses using selected strains showed that one strain adapted to the
host due to chronic infection, wherein the down-regulation of inflammatory cytokines in the host
associated with mycobacterial infection occurred as mutations accumulated [65].
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4. VNTR for MAC and Their Implications in Epidemiological Studies
Variable number tandem repeat (VNTR) is a genotyping method that analyzes the band size
after PCR amplification and electrophoresis using primers specific for the region surrounding the
VNTR sequence [66]. Since the repeat unit length of tandem repeats is known, this band size
allows for the calculation of a number of different VNTR copies per strain, ultimately presenting
the data as the number of VNTR repeats at each locus [67]. These quantitative data are particularly
useful for comparative studies within and between laboratories and countries. This includes the
VNTR of a genetic element called mycobacteria-interspersed repetitive units (MIRUs), which are
scattered throughout the genome of MTB, although they are predominantly located in the internal
regions [66,67]. In molecular epidemiology studies of M. avium, VNTR genotyping provides an
alternative to IS1245 RFLP genotyping [68]. This is because VNTR has higher reproducibility compared
to the short-term changes of IS1245 elements and does not require high DNA purity, as in RFLP
genotyping. Moreover, the discriminatory index of VNTR genotyping is similar to or higher than
that of IS1245 RFLP genotyping [68]. However, previous studies have suggested the use of RFLP
genotyping in combination with VNTR genotyping, as there are strains that could be identified
by IS1245 RFLP genotyping but not VNTR genotyping [68]. The following subsections detail the
identification of VNTR and MIRU loci, the development of genotyping techniques using these loci,
and the epidemiological indications.
4.1. Identification of VNTR Loci and Development of VNTR Techniques
In 2007, the MIRU-VNTR locus was identified using the genome sequence of the MAP K10 strain
for the study of MAP isolates [69]. Strain identification was validated not only in MAP, but also in M.
avium by IS1245 RFLP genotyping [39]. Comparative MIRU-VNTR analysis of M. avium and MAP
revealed that the 183 MAP isolates were grouped into only 21 types, whereas 82 M. avium isolates
were grouped into 30 types without overlapping patterns with MAP, demonstrating that the newly
developed MIRU-VNTR genotyping technique had a high discrimination power for M. avium [69].
However, as this genotyping method was developed using the MAP strain, there was a need to find
another locus to distinguish the MAC isolates, which led to the development of a new MATR-VNTR
primer. MATR-VNTR was generated based on several VNTR markers with the genetic information of
MAH 104 and MAP K10 [69–72]. MATR-VNTR genotyping resulted in a higher detection of M. avium
than MIRU-VNTR genotyping [68].
The VNTR locus was also selected using the M. intracellulare ATCC 13,950 standard strain, which
was applied to the M. intracellulare clinical isolates to confirm the high degree of identification [73].
Additionally, MIRU markers for M. intracellulare were established. Polymorphisms in the M. intracellulare
isolates and standard strain were identified using MIRU 1 and 4, which were established by [70] using
M. avium, MIRU 32, 292, X3, 25, 3, 7, 10, and 47 using MAP by [69], and all 16 loci from MAV 104, and
17 loci from M. intracellulare ATCC 13,950 by [74]. The following seven loci, except for those that were
not amplified or mutated, were identified and confirmed to be stable in 10 passages in medium: MIRU
3 [70], MIN 18, MIN 19, MIN 20, MIN 22, MIN 31, and MIN 33 (derived from M. intracellulare ATCC
13950) [74]. The detailed information of the studies involved genotyping and discriminant analyses of
MAC using VNTR and MIRU are summarized in Table 1.
The maximum Hunter–Gaston discriminatory index (HGDI) value was 0.172 using four MIRUs,
three TRs, and one MATR loci for MAS, 0.567 using four MIRU, and three TRs loci to 0.751 using eight
TR loci for MAP. M. avium, M. intacellulare, MAA, and MAH displayed an HGDI of 0.723 to 0.999 in
combination with various MIRU, MATR, and TR loci, indicating that VNTR genotyping of M. avium, M.
intacellulare, MAA, and MAH showed higher HGDI compared to MAS and MAP (Table 1). In particular,
in several studies using VNTR genotyping analysis applied to M. avium, MAA, MAH, and MAP, allelic
diversity for each MIRU, TR, RD, and MATR loci was obtained. The data are summarized in Table 2.
When allelic diversity (h) of VNTR loci was presented in the previous studies, the information was
presented directly in Table 2. However, if the h value was not presented directly in the literature, we
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extracted the VNTR type results from the results or supplementary data of the studies and calculated
their h values using these results. Genetic diversity at the locus extracted from each reference was
calculated as follows:
Allelic diversity index (h) = (1 −
∑
xi2) [n/(n − 1)], (0 ≤ h ≤ 1) (1)
where Xi is the relative frequency of the i-th gene locus, n is the total number of samples, and n/(n − 1)
is a value to correct the error due to the small number of samples [75].
As shown in Table 1, the HGDI of the VNTR technique was different depending on the species,
especially the combination of loci. Therefore, we present the allelic diversity (h) for each locus in
Table 2, and compared the allelic diversity for each locus according to infection sources, geographic
regions, and species. Few studies have used the MIRU locus compared to other loci, but showed
different h values for each species. In particular, MAP showed that each locus had a generally low h
value, so that the MAP genotype was less diverse than other species, or that the developed VNTR
technique had low discrimination power for MAP. Moreover, Iwamoto et al. (2012) analyzed MAH
isolates from humans, the environment, and animals using MATR loci. The h of each locus showed
similar trends in human and environmental isolates, and animals showed different h value trends.
However, animal isolates obtained in Switzerland tended to have different h values for each locus
compared to the animal isolates from Japan. Therefore, the genetic diversity of loci depending on
the source of infection is considered irrelevant. This information will be helpful for the selection of
locus suitable for research purposes when applying VNTR and VNTR-MIRU genotyping techniques
to MAC.
4.2. Application of VNTR Method for Clinical and Epidemiological Investigations
MIRU-VNTR analysis was performed using various sources of MAP 316F strains used for
vaccination. The identification of the strains used in vaccines is necessary, as there are large variabilities
within the same 316F strains [69]. In 2009, the association between the clinical features and molecular
epidemiology of the different strains was studied using the previously developed MATR-VNTR
genotyping technique [76]. In this study, the progression of lung disease caused by M. avium was
associated with a specific VNTR cluster. Additionally, among the three VNTR groups of clinical isolates,
isolates from patients with progressive disease were more likely to be in group C, whereas those from
patients with stable disease were more likely to be found in group A. Although the VNTR genotype
cannot determine the presence of lung disease, it can predict the progression of lung disease caused by
M. avium infection [76].
The study used a combination of MIRU and VNTR loci, and the association of VNTR clusters,
which had clinical significance. NTM infection and the presence of cavity were also related to the VNTR
type [77]. Additionally, the study confirmed the similarity between VNTR and PFGE profiling of M.
intracellulare patient isolates using seven MIRU loci. The combination of VNTR and 16S multiplex PCR
allowed for the determination of disease relapse [63]. The MATR loci were used to study the isolates
obtained from patients with pMAH135 plasmids containing pathogenic and antibiotic resistance genes
in MAH, which influence host specificity [78]. Additionally, the ability to be infected by human
macrophages and to proliferate were reported to depend on the VNTR type of MAH using MIRU
loci [79].
Moreover, MATR-VNTR genotyping was also used to evaluate the transmission between patients
with M. avium and the surrounding environment in which M. avium exists [80]. In this study, both M.
avium isolated from soil obtained from the patient’s residence and M. avium from the patient were
subjected to MATR-VNTR genotyping. The analysis revealed that there was a higher possibility of
two VNTR patterns matching if the patient was exposed to the soil [80]. This suggested that M. avium
may be transmitted directly to patients via the soil from its habitat to the patient’s residence [80].
Additionally, a follow-up study also confirmed that the frequency of exposure to environmental sources
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of M. avium was directly proportional to the number of detected M. avium isolates with various VNTR
patterns (polyclonal). This indicated that M. avium can be transmitted to patients via environmental
exposure [81]. The correlation between contact with the infected environmental and MAC infection
was analyzed even in the case of M. intracellulare [80,81].
In this study, minimum spanning tree (MST) analysis was performed by extracting the results
obtained using TR loci from the references cited in Tables 1 and 2. Using the extracted TR loci copy
numbers, MST results were obtained using the poppr package of the R software (version 2.8.3,) [82].
MST analysis was performed using MAH and MAP isolates according to infection sources and
geographic regions. As shown in Figure 1, MAP had only animal isolates, but there was no genetic
difference according to the geographic regions. In addition, MAH human and animal isolates were
either displayed the same genotype, or the isolates were located close to the cluster where the MAP
isolate was located. The results proved that MAH and MAP are genetically close. A comparative
genomic analysis of MAH reported that MAP already showed a reduced genome size and decreased
levels of genetic variability [83]. Thus, MAP is believed to be a host-adapted pathogen, which evolved
from MAH via genetic loss and acquisition [83,84]. MAH isolates were also divided into two large
clusters, one clustered with human, environment, and animal isolates, and the other with animal and
human isolates. Therefore, genotyping using TR loci could confirm the epidemiological relationships
between humans, the environment, and animals (Figure 1).
4.3. Geographical Relationship between Bacterial Strains Belonging to MAC
VNTR genotyping can also be used to study the association between strains. In particular,
VNTR genotyping is more suitable for the identification of MAA, MAH, and MAS than IS1311 RFLP
genotyping [85]. VNTR genotyping supports the hypothesis that MAA, MAP, and MAS evolved
independently in MAH [85]. However, for MAS, the variation between strains could not be confirmed
by VNTR genotyping [85]. Subsequent epidemiological studies using MATR markers confirmed the
association of MAH in isolates obtained from Dutch, German, US, Korean, and Japanese patients, and
found that the Japanese strains were genetically closer to the Korean strains than the European or
American strains [86]. Interestingly, the geographic origins or genetic associations of M. intracellulare
were not significantly related [86].
The association between animal and human isolates was also investigated. In the VNTR genotyping
analysis using MATR and MIRU loci, some MAH Swiss isolates from bovine lymph nodes were similar
to the pulmonary patient isolates from Netherlands, United States, and Japan [87]. The ISMav6 gene,
which is distributed predominantly among isolates obtained from a patient in East Asian regions, was
first found in isolates obtained from animals, indicating a close genetic association between the human
and animal strains [87]. Additionally, a comparison of VNTR types analyzed using MIRU and MATR
loci in previous studies of MANT BVLA01 strains isolated from cattle showed a close relationship
between isolates obtained from Japanese patients and from the bathtub [88]. That is, it was possible to
confirm the relationship between humans, the environment, and animal isolates, and not to have a
specific genotype indicating host specificity in MAH.
In this study, MST analysis was performed by extracting the results derived from 14-MATR
loci (MATR 1 to 16 excluding 9 and 10) from the references cited in Tables 1 and 2. MST analysis
was performed using MAH isolates according to the geographic regions. As shown in Figure 2,
clusters 2, 3, and 4 branched out around cluster 1, where the Korea-human and Japan-human
isolates and some Japan-environmental and Japan-animal isolates were occupied. Cluster 2 consisted
of Japan-animal isolates, United States, Germany, Netherlands-human isolates, and Japan-animal
isolates. Cluster 3 consisted of Japan-human and Japan-environment isolates, indicating no genetic
difference among isolates according to the infection source. In cluster 4, mainly United States and
Netherlands-human isolates had clustered, and genotyping analysis using MATR loci showed a rough
regional discrimination (Figure 2).
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4.4. Comparison of VNTR Using Other Genetic Typing Methods
Meanwhile, one study demonstrated that, when using the MIRU marker—which is considered to
be less effective than MATR—in combination with CCG-PCR, a type of rep-PCR, the identification
ability improved. In addition to the combination of NTR and the IS element RFLP genotyping method
previously recommended by Thibault et al. (2007) and Inagaki et al. (2009), a new method that
complements the MIRU marker with a new genotyping method was proposed [68,69,89].
Park et al. (2018) classified bison-type MAP strains isolated from Korea, which were identified
only by INMV 68 in the MIRU-VNTR typing, into three subtypes by MIRU-VNTR and eight subtypes
by multilocus short sequence repeat (MLSSR) typing [90]. The HGDI values in the MIRU-VNTR and
MLSSR were calculated to be 0.567 and 0.866, respectively, suggesting the combination of MLSSR
typing in MAP genotyping [90]. Additionally, and as described in this manuscript, MAP suggested
that each locus had a generally low h value, so that MIRU-VNTR typing could not provide a sufficient
epidemiological implication for MAP. Although MIRU-VNTR typing does not yield good discernment
in MAP and cannot be applied equally to all MACs, the epidemiological meanings can be obtained by
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Figure 1. A minimum spanning tree (MST) based on 7−TR (TR 292, X3, 25, 47, 7, 10, and 32)
genotyping for M. avium subsp. hominissuis (MAH) and M. avium subsp. paratuberculosis (MAP)
isolates from differe t geographic regions and sources. The strains used in this analysis were as
follows: isolates from Human−Argentina−MAH (n = 22, [95]), Human−Japan−MAH (n = 169, [96]),
Human−Italy−MAH (n = 22, [79]), Human−Finland−MAH (n = 13, [54]), Animal−Japan−MAH
(n = 141, [96]; n = 12, [88]), Animal−Finland−MAH (n = 16, [54]), Animal−Argentina−MAP
(n = 14, [69]; n = 61, [95]), Animal−France−MAP (n = 116, [69]), Animal−Italy−MAP (n = 2, [69]),
Animal−Netherlands−MAP (n = 27, [69]), Animal−Swed n−MAP (n = 2, [69]), Animal−Czech
Republic−MAP (n = 12, [69]), Animal−UK−MAP (n = 2, [69]), Animal−Venezuela−MAP (n = 2, [69]),
Animal−Slovenia−MAP (n = 1, [69]), Animal−USA−MAP (n = 2, [69]), Environment−Japan−MAH
(n = 37, [96]), and reference strains (MAP K10 and MAP ATCC 19698, [69]; MAA ATCC 15769, MAA
ATCC 25291, and MAA ATCC 35712, [54]). Each circle corresponds to the VNTR genotype, and the size
of the circle is proportional to the number of strains showing the same pattern. We performed MST
analysis based on VNTR genotypes using the poppr package of the R software (version 2.1.0) [82] to
reconstruct a hypothetical phylogenetic tree for the MAH and MAP isolates.
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Table 1. List of MIRU-VNTR loci and their discrimination power used for MIRU-VNTR typing applied to Mycobacterium avium complex.
Strain
Origin Sample No. VNTR Type Loci No. HGDI 1 Reference
Source Country
M. avium
AIDS patients France 82 30 types 8 TRs 0.889 [69]
Patients with/without pulmonary disease Japan 40 27 types 16 MATRs 0.945 [76]
HIV-negative patients with pulmonary MAC
infection Japan 70
56 MATR, 27 TR
types 15 MATRs, 8 TRs
MATR: 0.990
TR: 0.949 [68]
Patients Poland 33 21 types 8 TRs 0.945 [89]
Patients with pulmonary MAC infection and
residential soil samples Japan 88 78 types 15 MATR 0.997 [80]
Patients with pulmonary MAC infection Japan 310 93 types 15 MATR 0.987 [81]
Patients with pulmonary NTM infection China 41 29 types 13 MATRs 0.993 [91]
MAA
Bird, poultry, pig, wild animal, cat, bovine,
goat France 31 8 types 8 TRs 0.723 [85]
Diseased cattle, slaughtered pigs Germany 27 19 types
6 MIRUs, 2
VNTRs, 6 TRs, and
1 RD
0.966 [92]
Wild and domestic mammals, reptiles and
birds Hungary 135 16 types
4 MIRUs, 3 TRs,
and 1 MATR 0.845 [93]
MAH
Patients (HIV positive and negative), pig,
bovine, kangaroo, wild animal, soil sample France 82 23 types 8 TRs 0.807 [85]
Diseased cattle, slaughtered pigs Germany 16 15 types
6 MIRUs, 2
VNTRs, 6 TRs, and
1 RD
0.992 [92]
Patients Italy 47 8 types 8 TRs 0.862 [94]
Patients with pulmonary MAC infection (HIV
positive and negative) Japan 64 55 types 15 MATRs 0.995 [78]
Wild and domestic mammals, reptiles and
birds Hungary 84 33 types
4 MIRUs, 3 TRs,
and 1 MATR 0.966 [93]
Patients Argentina 26 16 types 8 TRs 0.93 [95]
Patients Italy 23 8 types 8 TRs 0.870 [79]
Slaughtered cattle Switzerland 26 14 types 15 MATRs, 5 TRs 0.972 [87]
Slaughtered bovine with abnormal pulmonary
case Japan 12 9 types 7 TRs, 14 MATRs 0.955 [88]
Humans, pigs and bathroom environments Japan 258 150 types 7 TRs, 15 MATRs 0.987 [96]
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Table 1. Cont.
Strain
Origin Sample No. VNTR Type Loci No. HGDI 1 Reference
Source Country
MAP






183 21 types 8 TRs 0.751 [69]





515 15 types 4 MIRU, 3 TRs 0.598 [97]
Cattle Argentina 61 5 types 8 TRs 0.6984 [95]
Cattle Korea 27 4 types 8 TRs 0.567 [90]
MAS
Wood pigeon France 4 1 type 8 TRs 0 [85]
Wild and domestic mammals, reptiles and
birds Hungary 62 5 types
4 MIRUs, 3 TRs,
and 1 MATR 0.172 [93]
M. intracellulare
Patients France 62 44 types 7 MIRUs 0.98 [74]
HIV-negative patients with pulmonary disease Japan 74 50 types 16 VNTRs 0.988 [73]
Patients with pulmonary MAC infection and
residential soil samples Japan 55 53 types 16 VNTRs 0.999 [80]
patients with nodular bronchiectasis USA 176 42 types 7 MIRUs 0.978 [63]
Patients with pulmonary MAC infection Japan 74 27 types 16 VNTRs 0.970 [81]
Patients with pulmonary MAC infection Japan, Korea, Netherlands,and USA 116 82 types 16 VNTRs 0.988 [86]
HIV-negative patients with pulmonary disease China 77 69 types 1 MIRU, 7 VNTRs 0.997 [77]
Patients with pulmonary NTM infection China 132 88 types 16 VNTRs 0.995 [91]
1 HGDI, Hunter-Gaston discriminatory index.
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Table 2. Allelic diversity index of MIRU-VNTR loci for Mycobacterium avium complex 1.
M. avium MAA MAH MAP
Sources Human Human Human Human/Environment Animal Animal Animal
Human/
Animal Human Human Animal Animal Animal Human Human Environment Animal
Human/
Animal Animal Animal Animal Animal








Sample No. 70 82 40 310 281 27 31 82 22 262 26 12 16 22 146 37 75 33 183 515 27 61
Reference [68] [69] [76] [81] [93] [92] [85] [85] [79] [86] [87] [88] [92] [95] [96] [96] [96] [54] [69] [97] [90] [95]
h 2
MIRU1 − − − − 0.250 − − − − − − − − − − − − − − 0.252 − −
MIRU2 − − − − 0.224 0.43 − − − − − − 0.52 − − − − − − 0.564 − −
MIRU3 − − − − 0.710 0.67 − − − − − − 0.7 − − − − − − 0.064 − −
MIRU4 − − − − 0.285 0.07 − − − − − − 0 − − − − − − 0 − −
MIRU5 − − − − − 0.07 − − − − − − 0.42 − − − − − − − − −
MIRU6 − − − − − 0.58 − − − − − − 0.57 − − − − − − − − −
MIRU7 − − − − − 0.22 − − − − − − 0.5 − − − − − − − − −
TR 25 0.512 0.33 − − 0.514 0.36 0 0.26 0.46 − 0.45 0.53 0.5 0.5844 0.517 0.47 0.593 0.55 0.07 0.094 0.446 0
TR 32 0.359 0.3 − − 0.471 − 0.03 0.17 0.21 − 0 0.21 − 0 0.484 0.497 0.101 0.19 0.59 0.032 0 0
TR 47 0.069 0.35 − − − 0.51 0 0.20 0.20 − 0.23 0 0.32 0.3247 0.116 0 0.444 0.43 0.05 − 0 0
TR 10 0.459 0.15 − − − − 0.21 0.13 0 − − 0.50 − 0.2554 − − − 0 0.18 − 0.036 0.0645
TR 259 − − − − 0.589 − − − − − − − − − − − − − − 0.063 − −
TR 3 − 0 − − − 0 0 0 0 − 0 − 0 0.0909 − − − 0 0.005 − 0 0
TR 7 0 0.04 − − − 0 0 0 0 − 0 0 0 0.4848 0 0 0 0 0.19 − 0 0.6980
TR 8 − − − − − 0.49 − − − − − − 0.65 − − − − − − − − −
TR 1685 − − − − − 0.51 − − − − − − 0.7 − − − − − − − − −
RD 130 − − − − − 0.21 − − − − − − 0.12 − − − − − − − − −
MATR−1 0.514 − 0.48 0.61 − − − − − 0.44 0.17 0 − − 0.494 0.307 0.231 − − − − −
MATR−2
(= TR 292) 0.581 0.27 0.59 0.63 − 0 0 0.19 0.46 0.71 0.64 0.53 0.6 0.5714 0.594 0.581 0.577 0.36 0.51 − 0.517 0.5050
MATR−3
(= TR X3) 0.571 0.72 0.60 0.57 − 0.52 0.64 0.68 0.54 0.67 0.71 0.21 0.56 0.5844 0.519 0.485 0.694 0.66 0.04 − 0 0
MATR−4 0.096 − 0.60 0.47 − − − − − 0.19 0.23 0.08 − − 0.08 0 0.593 − − − − −
MATR−5 0.096 − 0.12 0.20 − − − − − 0.37 0.52 0.08 − − 0.079 0 0.615 − − − − −
MATR−6 0.420 − 0.12 0.55 − − − − − 0.53 0.41 0.08 − − 0.492 0.272 0.47 − − − − −
MATR−7 0.718 − 0.65 0.68 − − − − − 0.79 0.55 0.23 − − 0.662 0.498 0.581 − − − − −
MATR−8 0.376 − 0.49 0.49 − − − − − 0.51 0.46 0.08 − − 0.463 0.497 0.657 − − − − −
MATR−9 0.459 − 0.49 0.65 0.445 − − − − − 0.66 − − − 0.512 0.272 0.494 − − − − −
MATR−10 − − 0.56 − − − − − − − − − − − − − − − − − − −
MATR−11 0.431 − 0.58 0.53 − − − − − 0.63 0.49 0.08 − − 0.515 0.482 0.576 − − − − −
MATR−12 0.000 − 0.02 0.09 − − − − − 0.16 0.47 0 − − 0.014 0.053 0.026 − − − − −
MATR−13 0.525 − 0.46 0.53 − − − − − 0.49 0 0.50 − − 0.506 0.456 0 − − − − −
MATR−14 0.480 − 0.53 0.52 − − − − − 0.50 0.31 0.08 − − 0.485 0.52 0.409 − − − − −
MATR−15 0.070 − 0.16 0.01 − − − − − 0.30 0.17 0.08 − − 0.118 0 0.517 − − − − −
MATR−16 0.400 − 0.53 0.50 − − − − − 0.48 0.35 0.45 − − 0.508 0.549 0.655 − − − − −
1 When allelic diversity (h) was presented in the references, this information was directly described in this table. Although h was not directly presented in the references, when the VNTR
type results could be extracted from the results or supplementary data, we calculated their h values using these results. 2 Allelic diversity index (h) = (1 −
∑
xi2) [n/(n − 1)], (0 ≤ h ≤ 1). In
this study, Selander’s formula was adopted and used [75]. Exceptionally, h values directly described in Iwamoto et al. (2012) [96] and Radomski et al. (2010) [85] are described by hand.
They used one of nei’s formulas, Iwamoto et al. (2012) for Keim et al. (2000) [98], and Radomski et al. (2010) for Nei et al. (1976) [99]. 3 Japan, Korea, Netherlands, and USA. 4 Argentina,
Czech Republic, France, Italy, Netherlands, Slovenia, Sweden, United Kingdom, USA, and Venezuela. 5 Denmark, France, Germany, Hungary, Italy, Netherlands, and Slovakia.
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Figure 2. A minimu spanning tree (MST) based o MATR (MATR to 16 excluding 9 and 10)
genotyping for M. avium subsp. hominissuis (MAH) isolates from different geographic regions and
sources. The strains used in this analysis were as follows: isolates from Human−USA (n = 32, [86]),
Human−Japan (n = 142, [96]; n = 94, [86]), Human−Germany (n = 10, [86]), Human−Netherlands (n =
27, [86]), Human−Korea (n = 98, [86]), Animal−Ja a (n = 45, [96]; n = 12, [88]), Environment−Japan (n
= 37, [96]), and M. avium 104. Each circle corresponds to the VNTR genotype, and the size of the circle
is proportional to the number of strains showing the same pattern. We performed MST analysis based
on VNTR genotypes using the poppr package of the R software (version 2.1.0) [82] to reconstruct a
hypothetical phylogen tic tree for the MAH isolates.
5. Rep−PCR Procedures and Their Implications in Epidemiological Studies
Rep−PCR analyzes the differences in band lengths by repeatedly amplifying between sequences
and scattering them within a chromosome using PCR [100]. There are several evolutionarily conserved
repetitive sequences in various strains, including BOX [101], enterobacterial intergenic consensus
(ERIC) [102], and the repetitive extragenic palindromes (REP) ele ent [103]. BOX elements are found
in Streptococcus pneumoniae, and the 57−bp sequence of the BoxA−like elements in several subunits is
conserved in various strains [101]. REP (38bp) and ERIC (126bp) are palindromic sequences, which
were first discovered in Escherichia coli and Salmonella typhimurium [104]. These elements are also
conserved in various strains that are systematically unrelated [104]. Additionally, polytrinucleotide
sequences, such as (GTG)5 or (GCC)5, which are scattered in the genomes of E. coli and S. typhimurium,
belong to the interspersed repetitive DNA sequences [105]. In mycobacteria, repetitive sequences were
identified in M. bovis and MTB [106]. The epidemiological and clinical implications of the studies that
have been applied to genotyping for MAC using rep−PCR are summarized in Table 3.
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5.1. Application of Rep−PCR to Epidemiological Investigations of MAC
IS900, a MAP−specific IS element with similar sequences in other mycobacteria, limits the detection
of MAP by PCR. The development of alternative PCR assays was thus necessary to perform a rapid
analysis; as a result, ERIC/IS900 PCR was developed using both ERIC and IS900 sequences [107].
ERIC/IS900 PCR analysis revealed that MAP exhibits a species−specific band pattern, which can be
used to distinguish MAP from other mycobacteria [107]. However, all the MAP strains that were
previously classified using RFLP analysis could not be identified by ERIC/IS900 PCR analysis and
cannot be used as an alternative to RFLP analysis [107]. However, this study suggested that a repetitive
sequence for MAC can be used for epidemiological analysis. The mycobacterium strain genotyping kit
from DiversiLab was released in 2003 for rep−PCR of the BOX, ERIC, and REP sequences, as reported
by Versalovic et al. (1991) and Koeuth et al. (1995) [108]. This kit was used for a comparative analysis
of IS1245−RFLP and rep−PCR patterns of M. avium. Additionally, the rep−PCR analysis was used
independently for M. intracellulare. There was 96% similarity between RFLP and rep−PCR patterns,
except for the strains with little or no IS elements [108]. It was estimated that the ability of rep−PCR
was similar to or higher than that of RFLP, and that the complex pattern of M. intracellulare could be
identified as a result [108].
Additionally, rep−PCR was performed directly using the primers designed by Versalovic et
al. (1991) and Koeuth et al. (1995) instead of the commercial kit, classified 176 M. intracellulare
isolates into only three types compared to the nine types classified by VNTR, indicating that the
primers designed by Versalovic et al. (1991) and Koeuth et al. (1995) may not be suitable for the
diagnosis of a M. intracellulare relapse [63]. Meanwhile, the study by Otsuka et al. (2004) found
that trinucleotide repetitive sequence−based PCR (TRS−PCR) could be used to identify not only M.
tuberculosis and M. bovis strains, but also M. avium strains [109]. This led to the studies identifying
strains in MAC or the same species strains of MAC via (CCG)4−PCR, revealing a high diversity index
of 0.979 and reproducibility of 95.1%. These findings indicated that the combined use of MIRU−VNTR
and (CCG)4−PCR analysis could be used for the identification of M. avium [89].
5.2. Implication of Rep−PCR Methods in MAC Epidemiological Investigations
In subsequent experiments, M. avium clinical isolates (not MAP) were collected from various
countries to investigate the current distribution of the MAH 104 strain, which was first isolated from
California in 1983 [110]. Large sequence polymorphism PCR (LSP PCR) was performed to confirm the
presence of four hypervariable genomic regions. The rep−PCR analysis of 19 strains with the same
LSP types as MAV104 revealed that 10 strains had the same pattern as MAH 104 [110]. As these 10
strains were collected from 10 different patients over 17 years at five clinical sites in the West Coast of
the United States, it was confirmed that MAV104 still results in disease in many patients in the West
and that its genotype remains consistent over time [110].
Subsequently, a study was conducted to determine whether M. avium detected in patients via
bronchoscopy were, in fact, pathogens or contamination from the bronchoscope [111]. Of the 22 M.
avium clinical isolates and 56 M. intracellulare clinical isolates, 5 (23%) and 42 (75%) isolates were
similar to those detected in the bronchoscope and the water in the preparation room used to wash the
bronchoscope, respectively [111]. Notably, over 10% of MAC isolates were able to survive even after 3
to 4 h of exposure to hot water with a temperature of 60 ◦C or above [112], suggesting that the samples
isolated from patients have a high probability of being contaminated by a bronchoscope washed
with water, and that even healthy individuals could be exposed to MAC during bronchoscopy [111].
Following this study, the plumbing lines that supplied water to the homes of the patients were examined.
Of the 37 households studied, 17 (46%) had the same NTM species as the isolate obtained from the
patient, including MAC [61]. Additionally, the rep−PCR analysis revealed that these strains were the
same, which indicated the possibility of MAC infection among households [61]. However, one study
reported that infection relapse in HIV patients with M. avium bacteremia post−high−efficiency AIDS
treatment was caused by the same strain [113]. The rep−PCR pattern of M. avium isolates exhibited
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64–78% consistency with that of the control isolates, while the rep−PCR patterns exhibited 99.5%
consistency among the M. avium isolates [113]. As these previous studies suggest that MTB can be
latent in adipocytes, further studies are necessary to confirm whether MAC is also latent, in order to
develop strategies for the prevention of MAC relapse in patients with AIDS [113]. Similarly, rep−PCR
analysis revealed that the continued relapse of MAH in patients with hypersensitivity pneumonitis
was caused by hot tubs installed in their homes. Upon discontinuation of hot tub use, the health of
the patient improved. This demonstrated the importance of rep−PCR analysis in determining patient
treatment [114].
5.3. Clinical Application of MAC Rep−PCR
Rep−PCR is widely used in clinical studies due to its simplicity. Recently, the difference in
treatment outcome or relapse according to the phenotypes of MAC lung disease (MAC−LD) was
evaluated in 481 patients with MAC−LD, demonstrating a 29% relapse rate among patients with
good treatment outcomes. Additionally, this study demonstrated that the phenotype of nodular
bronchiectasis was a significant risk factor for relapse and that 74% of relapses were due to reinfection
by other strains [115]. Daily and intermittent treatments with antibiotics for recurrent noncavitary
nodular bronchiectatic (NB)−type MAC−LD were compared by rep−PCR analysis, which revealed
that reinfection by strains with a new genotype was the cause for 86% of the case of relapse and the
antibiotic toxicity of daily treatment. This indicated that intermittent treatment was appropriate for
this disease [116]. Subsequently, a study was conducted to determine whether antibiotic resistance or
reinfection was responsible for the positive culture exhibited by patients with refractory MAC−LD,
even after treatment with macrolide antibiotics for over 12 months. The analysis revealed that 22%
of patients treated for an average of 33 months were resistant, and 73% of relapsed patients were
re−infected with a new strain of MAC. This confirmed that reinfection was a more important factor in
refractory MAC−LD than macrolide resistance [41].
Currently, the rep−PCR analysis of the MAC complex is mainly being performed using commercial
kits. Additionally, the primers designed by Versalovic et al. (1991) and Koeuth et al. (1995) are
commonly used. However, the commercial product was discontinued and the primers designed by
Versalovic et al. (1991) and Koeuth et al. (1995) are considered to have a low identification capability.
As rep−PCR analysis could be used to diagnose the cause of relapse more quickly and more easily
than PFGE or VNTR methods, it is important to develop primers that can identify MAC complex more
effectively than the currently available options.
6. Conclusions and Perspectives
MAC is the most frequently isolated species that causes human disease among NTM across the
world. With an increasing understanding of the genetic diversity, differential pathogenicity, and varied
infectious sources of MAC, new MAC species and subspecies are constantly being identified. Certain
environments, such as in water and soil, likely become a niche for M. avium and M. intracellulare. M.
avium that is excreted from infected animals contaminates the environment, but no evidence exists for
similar environmental contamination by M. intracellulare. However, the transmission mode of MAC
with specific genetic characteristics is not yet clearly defined, and more reliable and feasible genotyping
methods of MAC are urgently needed. As summarized in this review, several genotyping methods
based on unique genetic markers of MAC species and subspecies might improve our understanding of
estimating the infection pathway among animals, humans, and the environment, and evaluation of the
treatment strategies based on the treatment outcomes and the pattern of recurrence of MAC infection.
The establishment and application of criteria for the selection of the appropriate genotyping techniques
for each MAC strain and the relevant epidemiological investigations will allow for the improvement of
public health preventive measures and for an increased effectiveness of MAC patient management.
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Table 3. List of rep−PCR based genotyping methods applied to Mycobacterium avium complex.










- As a result of ERIC/IS900 PCR using the ERIC sequence and
IS900 for the epidemiological analysis of MAP, MAP showed
species−specific band patterns, which can be used as a method
for discriminating it from other mycobacteria.
- However, the MAP strains that were discriminated by RFLP
cannot be distinguished and thus cannot be used as an
alternative genotyping method of RFLP.
[107]



















− The genetic analysis pattern of RFLP and rep−PCR is 89%
concordant, such that the genetic discrimination of
rep−PCR is equal to or better than that of RFLP. [108]
M. intracellulare Human patients USA 8 DiversiLabMycobacterium kit
− Eight M. intracellulare clinical isolates showed different
patterns with rep−PCR.






− The isolates from ten different patients at five clinical sites
in the western US were genetically identical to the
standard strain MAH 104.
− The bacterium is involved in causing disease in many
patients in the western US, indicating that the genotype
of the pathogen is stable over time.
[110]





USA 22 clinical,16 laboratory
Cangelosi et al.,
2004
- Water and biofilm samples collected from the bronchoscopy
preparation laboratory yielded mycobacteria, including M.
avium and M. intracellulare.
- It is assumed that infection with 5/22 (23%) M. avium isolates
and 42/56 (75%) M. intracellulare isolates is the result of a
contaminated water supply
[111]





USA 56 clinical,4 laboratory
Cangelosi et al.,
2004
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Table 3. Cont.
Strain Origin Country Sample No. Primers Epidemiologic Characteristics Reference









- Of the 17 strains of MAC strains isolated during 2007–2009 in
water distribution system of 37 patients, seven strains had the
same genotype as the patients (matching rate 41%).
[61]















USA 6 clinical,33 environment
Cangelosi et al.,
2004
− Three isolates from household samples of chronic rhinitis
patients previously infected with NTM were genetically
associated with the isolate identified in the patient.
− This suggests that chronic rhinitis patients may be
infected with NTM in their own household.
[43]
M. avium Human Patients with HIVpositive France 8
DiversiLab
Mycobacterium kit
− The genetic reconciliation between 2002 and 2009 isolates
was 99.5% in patients who relapsed 7 years after their first
infection by M. avium.
[113]
M. avium Human clinical isolates Poland 33 N6(CCG)4
− The discrimination index of (CCG)4−PCR for M. avium
was 0.979, which was higher than 0.945 obtained for
MIRU−VNTR (TR32, TR292, TRX3, TR25, TR7, TR10, and
TR47).
− However, MIRU−VNTR was able to distinguish certain
strains that (CCG)4−PCR could not. As such, a
combination of (CCG)4−PCR and MIRU−VNTR is




household sample Netherlands 5
DiversiLab
Mycobacterium kit
− MAH is still detected after treatment of hypersensitivity
pneumonia, suggesting relapse in infection due to the use
of contaminated hot tubs found in the patients’ houses.
− Rep−PCR analysis confirmed that the strain isolated from
the patient was the same as the hot tub isolate. Thus, after







USA 176 Versalovic et al.1991
− Genotyping was performed using PFGE, MIRU−VNTR
(MIRU 3, MIN 18, 19, 20, 22, 31, 33), rep−PCR, and ITS
region sequencing using 176 M. intracellulare.
− Thecombination of VNTR and 16S multiplex PCR has a
similar reliability to PFGE.
− Rep−PCR is excluded because of its low level of
discrimination power of rep−PCR in the identification
of relapse.
[63]
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− As a result of comparing the discrimination between
several types of genotyping methods(hsp65 sequencing,
LSP, 4−locus MIRU, and 8−locus MIRU) including
rep−PCR, LSP−MVR (a combination of LSP and
MIRU−VNTR)was selected as the high resolution
genotyping method.







South Korea 31 DiversiLabMycobacterium kit
- In 481 patients with MAC lung disease who received antibiotic
therapy for over 12 months were associated with re−infection
by other bacteria (74%), while 26% of recurrence resulted from
infection by the same bacteria (26%), according to the rep−PCR
results.
- The NB form was also determined as a significant risk factor







South Korea 34 DiversiLabMycobacterium kit
M. avium Human Patients withMAC lung disease South Korea 52
DiversiLab
Mycobacterium kit
- The therapeutic effectiveness of intermittent antibiotic therapy
was evaluated in patients previously treated for MAC lung
disease and receiving antibiotic treatment for recurrent
noncavitary NB MAC lung disease
-86% (12/14) of relapsed patients were found to be infected with
a new strain of MAC
-As such, intermittent antibiotic therapy was suggested
intermittent antibiotic therapy as to be a reasonable treatment
strategy for recurrent noncavitary NB MAC lung disease.
[116]







South Korea 80 DiversiLabMycobacterium kit
- In 72 patients with refractory M. avium complex lung disease
(MAC−LD) who received antibiotic therapy, including
macrolides, for over 12 months, macrolide resistance was found
in 16 patients (22%).
- Of the 49 patients recorded before and after treatment, 24/49
(49%) patients were found to be infected with a new MAC
strain, while 12/49 (24%) patients were infected by both the
original and new strains. Only 13/49 patients (27%) showed
persistent infection by the original MAC strain.
- In conclusion, refractory MAC−LD is generally caused by
reinfection of other strains rather than the relapse of the
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